Novozymes completes acquisition of Iogen’s industrial enzyme business

Novozymes and Iogen (Ottawa, ON) say that the previously announced acquisition of Iogen Bio-Products, the industrial enzyme business of Iogen, by Novozymes has been completed. It was announced on 31 January that Novozymes would acquire Iogen Bio-Products for C$67.5 million ($66 million) and potential earn-out payments of up to C$12.5 million. The closing conditions for the transaction have been met, and the acquisition has been completed, the companies say. Iogen Bio-Products, which entered the industrial enzyme industry in 1991, produces and sells enzymes for...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers